BioSpace News Archive

Recognizes ‘care, dedication and commitment’ of ordinary people

The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) (“ACADIA”) on behalf of purchasers of ACADIA securities between April 29, 2016 and July 9, 2018, inclusive (the “Class Period”).

On February 6, 2018, Sinovac Biotech Ltd. held its 2017 Annual Meeting of Shareholders in Beijing, China.

Leading dermatology EHR company showcases new functionality at Summer AAD 2018

Personalis, Inc., a leading provider of advanced genomic sequencing and analytics for immuno-oncology (IO), today announced that it has received approval from the New York State Department of Health for use of ACE ImmunoID, its next-generation sequencing platform for the development of personalized cancer vaccines and IO biomarker discovery, in cancer immunotherapy clinical trials.

As part of Amgen’s planned executive succession to address upcoming retirements, the Company announced transition plans for two of its executive vice presidents today.

Expects Revenue Growth of at Least 20% for Fiscal Year 2019

Planet Fitness, Inc. announced that the Company will report results for its second quarter ended June 30, 2018 after the market closes on Thursday, August 9, 2018.

The Canadian Medical Association (CMA) has been pursuing improved health care and quality of life for our aging population for the past five years.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased ACADIA Pharmaceuticals Inc.